Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans

2019 ◽  
Vol 25 (6) ◽  
pp. 805-812 ◽  
Author(s):  
Lucia Černáková ◽  
Stanislava Dižová ◽  
Dana Gášková ◽  
Iva Jančíková ◽  
Helena Bujdáková



2014 ◽  
Vol 117 (3) ◽  
pp. 618-626 ◽  
Author(s):  
J. Shao ◽  
T. Wang ◽  
Y. Yan ◽  
G. Shi ◽  
H. Cheng ◽  
...  


2016 ◽  
Vol 61 (1) ◽  
Author(s):  
L. F. Reis de Sá ◽  
F. T. Toledo ◽  
A. C. Gonçalves ◽  
B. A. Sousa ◽  
A. A. dos Santos ◽  
...  

ABSTRACT Invasive Candida albicans infections are a serious health threat for immunocompromised individuals. Fluconazole is most commonly used to treat these infections, but resistance due to the overexpression of multidrug efflux pumps is of grave concern. This study evaluated the ability of five synthetic organotellurium compounds to reverse the fluconazole resistance of C. albicans clinical isolates. Compounds 1 to 4, at <10 μg/ml, ameliorated the fluconazole resistance of Saccharomyces cerevisiae strains overexpressing the major C. albicans multidrug efflux pumps Cdr1p and Mdr1p, whereas compound 5 only sensitized Mdr1p-overexpressing strains to fluconazole. Compounds 1 to 4 also inhibited efflux of the fluorescent substrate rhodamine 6G and the ATPase activity of Cdr1p, whereas all five of compounds 1 to 5 inhibited Nile red efflux by Mdr1p. Interestingly, all five compounds demonstrated synergy with fluconazole against efflux pump-overexpressing fluconazole-resistant C. albicans clinical isolates, isolate 95-142 overexpressing CDR1 and CDR2, isolate 96-25 overexpressing MDR1 and ERG11, and isolate 12-99 overexpressing CDR1, CDR2, MDR1, and ERG11. Overall, organotellurium compounds 1 and 2 were the most promising fluconazole chemosensitizers of fluconazole-resistant C. albicans isolates. Our data suggest that these novel organotellurium compounds inhibit pump efflux by two very important and distinct families of fungal multidrug efflux pumps: the ATP-binding cassette transporter Cdr1p and the major facilitator superfamily transporter Mdr1p.



2015 ◽  
Vol 59 (7) ◽  
pp. 4289-4292 ◽  
Author(s):  
Sofia Costa-de-Oliveira ◽  
Isabel M. Miranda ◽  
Ana Silva-Dias ◽  
Ana P. Silva ◽  
Acácio G. Rodrigues ◽  
...  

ABSTRACTCandida albicansis the most prevalent cause of fungemia worldwide. Its ability to develop resistance in patients receiving azole antifungal therapy is well documented. In a murine model of systemic infection, we show that ibuprofen potentiates fluconazole antifungal activity against a fluconazole-resistant strain, drastically reducing the fungal burden and morbidity. The therapeutic combination of fluconazole with ibuprofen may constitute a new approach for the management of antifungal therapeutics to reverse the resistance conferred by efflux pump overexpression.



Author(s):  
Babak Pourakbari ◽  
Mostafa Teymuri ◽  
Shima Mahmoudi ◽  
Sepideh K. Valian ◽  
Zahra Movahedi ◽  
...  




2018 ◽  
Vol 9 ◽  
Author(s):  
Jin-Hyung Lee ◽  
Yong-Guy Kim ◽  
Vivek Kumar Gupta ◽  
Ranjith Kumar Manoharan ◽  
Jintae Lee


Sign in / Sign up

Export Citation Format

Share Document